Article Versions Notes

Chojnowski K, Opiełka M, Gozdalski J, Radziwon J, Dańczyszyn A, Aitken AV, Biancardi VC, Winklewski PJ. The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review. International Journal of Molecular Sciences. 2023; 24(3):2119. https://doi.org/10.3390/ijms24032119

Chojnowski, Karol, Mikołaj Opiełka, Jacek Gozdalski, Jakub Radziwon, Aleksandra Dańczyszyn, Andrew Vieira Aitken, Vinicia Campana Biancardi, and Paweł Jan Winklewski. 2023. "The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review" International Journal of Molecular Sciences 24, no. 3: 2119. https://doi.org/10.3390/ijms24032119

Chojnowski, K., Opiełka, M., Gozdalski, J., Radziwon, J., Dańczyszyn, A., Aitken, A. V., Biancardi, V. C., & Winklewski, P. J. (2023). The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review. International Journal of Molecular Sciences, 24(3), 2119. https://doi.org/10.3390/ijms24032119